聞泰科技(600745.SH)漲停 上半年半導體業績亮眼
格隆匯8月30日丨聞泰科技(600745.SH)封漲停板,報價124.15元,市值1546億元。公司上週五晚公佈業績顯示,2021年上半年營收247.69億元,同比漲3.91%;淨利潤12.32億元,同比降27.56%。公司並未在報吿中直接解釋淨利潤下降的原因,但分析人士稱ODM業務是拖累聞泰科技業績下滑的主要原因。另外值得注意的是,公司半導體業績表現亮眼。中報顯示,公司上半年半導體業務收入67.73億元,同比增53.25%,業務毛利率35.06%,淨利潤13.1億元,同比增234.52%。盈利能力達到歷史最高水平,半導體業務保持快速增長態勢。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.